Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
19 participants
INTERVENTIONAL
2014-01-28
2015-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet Rich Plasma in Knee Osteoarthritis
NCT05080075
Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma
NCT02365142
Intra-articular Infiltration of Platelet-Rich Fibrin vs Corticosteroid in Mild to Moderate Knee Osteoarthritis
NCT06905860
Optimal Articular Solutions With Intraosseous and Synovial Platelet-Rich Plasma
NCT06520059
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
NCT05737173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Platelet Rich Plasma
Combination of Intraarticular and Intraosseous Administraion of Platelet Rich Plasma
Platelet Rich Plasma
Combination of Intraosseous and Intraarticular Infiltration of Platelet Rich Plasma
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet Rich Plasma
Combination of Intraosseous and Intraarticular Infiltration of Platelet Rich Plasma
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Predominant internal tibiofemoral knee osteoarthritis.
* Joint pain above 2.5 VAS points.
* Radiographic severity degrees 3 and 4 according to Ahlbäck scale.
* Values of body mass index between 20 and 33.
* Possibility for observation during the follow-up period.
Exclusion Criteria
* Values of body mass index \> 33.
* Polyarticular disease diagnosed.
* Severe mechanical deformity (diaphyseal varus of 4∘ and valgus of 16∘).
* Arthroscopy in the last year prior to treatment.
* Intra-articular infiltration of hyaluronic acid in the past 6 months.
* Systemic autoimmune rheumatic disease (connective tissue diseases and systemic necrotizing vasculitis).
* Poorly controlled diabetes mellitus (glycosylated hemoglobin above 9%).
* Blood disorders (thrombopathy, thrombocytopenia, and anemia with Hb \< 9).
* Undergoing immunosuppressive therapy and/or warfarin.
* Treatment with corticosteroids during the 6 months prior to inclusion in the study.
40 Years
77 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unidad de Cirugía Artroscópica
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCA-01-EC/13/ART
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.